Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yen-Yi Lin

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Bioinformatics (Oxford, England)|April 5, 2018
MechRNA: prediction of lncRNA mechanisms from RNA-RNA and RNA-protein interactionsAlexander R Gawronski, Michael Uhl, Yajia Zhang, et al.
Molecular Cancer Research : MCR|January 8, 2025
Exploring B7-H4's Role in Prostate Cancer Dormancy after Androgen Deprivation Therapy: Extracellular Matrix Interactions and Therapeutic OpportunitiesNing Kang, Hui Xue, Nelson K Y Wong, et al.
Molecular Cancer Therapeutics|March 10, 2025
5'-S-(3-aminophenyl)-5'-thioadenosine, a novel chemoprotective agent for reducing toxic side effects of fluorouracil in treatment of MTAP-deficient cancersSi Zhang, Hui Xue, Nelson K Y Wong, et al.
Cancer Science|May 7, 2021
Establishment and characterization of a novel treatment-related neuroendocrine prostate cancer cell line KUCaP13Kosuke Okasho, Kei Mizuno, Tomohiro Fukui, et al.
Cancer Research|May 9, 2019
Upregulation of Scavenger Receptor B1 Is Required for Steroidogenic and Nonsteroidogenic Cholesterol Metabolism in Prostate CancerJacob A Gordon, Jake W Noble, Ankur Midha, et al.
Cell Genomics|June 11, 2025
CXCR4-LASP1-G9a-SNAIL axis drives NEPC transdifferentiation via induction of EMT and downregulation of RESTLiangliang Liu, Itzel Astiazarán Rascón, Dong Lin, et al.
International Journal of Molecular Sciences|February 27, 2026
Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on <i>KRAS/NF1</i> Mutational StatusMadison Bittner, Marta Llaurado Fernandez, Joshua Hoenisch, et al.
Translational Oncology|November 7, 2025
Establishment and characterization of preclinical models of human gynecologic tract carcinosarcomas demonstrates targetable FGFR1 alterationsNelson K Y Wong, Marta Llaurado Fernandez, Hannah Kim, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Deciphering the Transcription Factor Landscape in Neuroendocrine Prostate Cancer Progression: A Novel Approach to Understand NE TransdifferentiationYu Wang, Hui Xue, Xiaohui Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 17, 2025
Deciphering the Transcription Factor Landscape in Prostate Cancer Progression: A Novel Approach to Understand NE TransdifferentiationYu Wang, Hui Xue, Xiaohui Zhu, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Bioinformatics (Oxford, England)|April 5, 2018
MechRNA: prediction of lncRNA mechanisms from RNA-RNA and RNA-protein interactionsAlexander R Gawronski, Michael Uhl, Yajia Zhang, et al.
Molecular Cancer Research : MCR|January 8, 2025
Exploring B7-H4's Role in Prostate Cancer Dormancy after Androgen Deprivation Therapy: Extracellular Matrix Interactions and Therapeutic OpportunitiesNing Kang, Hui Xue, Nelson K Y Wong, et al.
Molecular Cancer Therapeutics|March 10, 2025
5'-S-(3-aminophenyl)-5'-thioadenosine, a novel chemoprotective agent for reducing toxic side effects of fluorouracil in treatment of MTAP-deficient cancersSi Zhang, Hui Xue, Nelson K Y Wong, et al.
Cancer Science|May 7, 2021
Establishment and characterization of a novel treatment-related neuroendocrine prostate cancer cell line KUCaP13Kosuke Okasho, Kei Mizuno, Tomohiro Fukui, et al.
Cancer Research|May 9, 2019
Upregulation of Scavenger Receptor B1 Is Required for Steroidogenic and Nonsteroidogenic Cholesterol Metabolism in Prostate CancerJacob A Gordon, Jake W Noble, Ankur Midha, et al.
Cell Genomics|June 11, 2025
CXCR4-LASP1-G9a-SNAIL axis drives NEPC transdifferentiation via induction of EMT and downregulation of RESTLiangliang Liu, Itzel Astiazarán Rascón, Dong Lin, et al.
International Journal of Molecular Sciences|February 27, 2026
Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on <i>KRAS/NF1</i> Mutational StatusMadison Bittner, Marta Llaurado Fernandez, Joshua Hoenisch, et al.
Translational Oncology|November 7, 2025
Establishment and characterization of preclinical models of human gynecologic tract carcinosarcomas demonstrates targetable FGFR1 alterationsNelson K Y Wong, Marta Llaurado Fernandez, Hannah Kim, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Deciphering the Transcription Factor Landscape in Neuroendocrine Prostate Cancer Progression: A Novel Approach to Understand NE TransdifferentiationYu Wang, Hui Xue, Xiaohui Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 17, 2025
Deciphering the Transcription Factor Landscape in Prostate Cancer Progression: A Novel Approach to Understand NE TransdifferentiationYu Wang, Hui Xue, Xiaohui Zhu, et al.
Pageof 4